Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement
Journal of Clinical Medicine · 26.08.2025 · 14 (17) · 6034
DOI: 10.3390/jcm14176034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.08.2025. Verfasst von Sheena Patel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Swedish Orphan Biovitrum AB, 113 64 Stockholm, Sweden. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Orphan Biovitrum AB, Apellis Pharmaceuticals, Inc, Apellis Pharmaceuticals, Inc..
Abstract (Originalsprache)
Adherence to medications is a significant challenge in chronic disease management. Poor adherence can lead to adverse patient outcomes including disease progression, increased morbidity, reduced quality of life, higher hospitalization rates, increased medical costs, and mortality. Medical adherence is a complex issue, influenced by multiple factors, including patient-related, medication-related, and healthcare system-related barriers. This review explores reasons for both intentional non-adherence, such as patients underestimating the consequences of the disease, inadequate education or poor healthcare provider–patient communication, and unintentional non-adherence, including forgetfulness, pathophysiological barriers, socioeconomic barriers (including lifestyle and patient factors), or healthcare resource limitations. Multifaceted, patient-tailored interventions that could improve adherence are discussed, including promoting health education, enhancing healthcare provider–patient engagement, and exploring alternative medical solutions and emerging technological advances. No single approach fits all; this review aims to deepen the understanding of intentional and unintentional non-adherence and to inform targeted interventions to empower patients, foster trust, and improve adherence for those with chronic conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Swedish Orphan Biovitrum AB, 113 64 Stockholm, Sweden.
- Apellis Pharmaceuticals Inc., Waltham, MA 02451, USA.
- Sophia Miliara, Norra Stationsgatan 93A, 113 64 Stockholm, Sweden.
ORCID-Profile: Sheena Patel, Mingyi Huang, Sophia Miliara
Förderung
- Swedish Orphan Biovitrum AB
- Apellis Pharmaceuticals, Inc
- Apellis Pharmaceuticals, Inc.
Zitieren
APA
Patel, S., Huang, M., & Miliara, S. (2025). Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement. Journal of Clinical Medicine, 14(17), 6034. https://doi.org/10.3390/jcm14176034
Vancouver
Patel S, Huang M, Miliara S. Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement. Journal of Clinical Medicine. 2025;14(17):6034. doi:10.3390/jcm14176034
BibTeX
@article{Patel2025,
author = {Patel, Sheena and Huang, Mingyi and Miliara, Sophia},
title = {Understanding Treatment Adherence in Chronic Diseases: Challenges, Consequences, and Strategies for Improvement},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {17},
pages = {6034},
doi = {10.3390/jcm14176034}
}
EUVIMED